Functional metabolomics using UPLC-Q/TOF-MS combined with ingenuity pathway analysis as a promising strategy for evaluating the efficacy and discovering amino acid metabolism as a potential therapeutic mechanism-related target for geniposide against alcoholic liver disease

Abstract

Metabolomics has been used as a promising strategy to evaluate the efficacy of and potential targets for natural products. Alcoholic liver disease (ALD) as a result of chronic ethanol consumption has high morbidity and mortality. Geniposide possesses a hepatoprotective activity against ALD, but its mechanism of action is still not clear. In this study, serum metabolomics based on ultra-performance liquid chromatography-quadrupole time of flight-tandem mass spectrometry (UPLC-Q/TOF-MS) combined with ingenuity pathway analysis was used to explore the therapeutic mechanisms of geniposide. We found that the levels of AST, ALT, MDA, TG, and γ-GT in the geniposide-treated group were significantly decreased, and the level of GSH was significantly increased, compared with the model group. Meanwhile, geniposide effectively inhibits apoptosis and caspase-3 activity in liver tissue. A total of 33 metabolites were identified and related with the model group to illuminate the pathogenesis of ALD, 21 of which are regulated by geniposide, involving the relevant metabolic pathways, such as amino acid metabolism, arachidonic acid metabolism, pyruvate metabolism, TCA cycle, etc. Furthermore, a significant change in amino acid metabolism suggested that it might be a promising mechanism-related target for geniposide against ALD. It also showed that a metabolomic strategy using UPLC-Q/TOF-MS combined with ingenuity pathway analysis is a potentially powerful tool for providing a comprehensive understanding of the therapeutic mechanisms of natural products, but it also offers a theoretical basis for the prevention or treatment of disease.